Publications

Explore our publications.

Publications and congress materials may include information about investigational uses or investigational products. Such information is provided for scientific exchange only and is not intended to imply that any investigational product or use has been approved by FDA or that safety or effectiveness has been established.

Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results of a Phase 3 Study

Poster Presentation

Efficacy and safety of telitacicept in participants with Sjögren’s disease: Results from a multicenter, randomized, double-blind, placebo-controlled, phase 3 clinical study

Poster Presentation

Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results from a Phase 3 Study

Oral Presentation

Global Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis (RemeMG)

Abstract

Poster Presentation

Have a question? Submit a medical information request.

Learn More

Publications

Explore our publications.

Filter By:

American Academy of Neurology (AAN 2025)

Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results of a Phase 3 Study

American College of Rheumatology (ACR 2025)

Efficacy and safety of telitacicept in participants with Sjögren’s disease: Results from a multicenter, randomized, double-blind, placebo-controlled, phase 3 clinical study

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM 2025)

Efficacy and Safety of Telitacicept in Patients with Generalized Myasthenia Gravis: Results from a Phase 3 Study

Carrell-Krusen Neuromuscular Symposium (CK 2026)

Global Phase 3 Study to Evaluate the Efficacy and Safety of Telitacicept in Patients With Generalized Myasthenia Gravis (RemeMG)

Have a question? Submit a medical information request.

By selecting “Yes,” you confirm that you are a U.S.-based healthcare professional and that you are accessing this site for scientific and medical information. This site is not intended for patients, caregivers, or non-U.S. audiences.